相关实验视频

Updated: Jan 8, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

已故供体肝移植使用MELD 3.0的生存益处:当代分析

Gabrielle Jutras¹, John P Roberts², Amy M Shui³

¹Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

|December 11, 2025

概括

该研究使用MELD 3.0分数重新评估了已故供体肝移植 (DDLT) 的生存益处值. DDLT在MELD 3.0分数为12及以上时显示出生存益处,修改了之前的15的门.

科学领域:

肝病学肝病学是一种肝病学.
移植手术移植手术
医学统计医学统计

背景情况:

肝移植 (LT) 的决定取决于平衡移植前的死亡风险和移植后的存活率,称为"存活益处".
2005年的一项研究确定了15的MELD得分作为已故供体肝移植 (DDLT) 存活益处的门,这是一个仍然具有影响力的基准.
本研究使用更新的MELD 3.0评分系统批判性地检查了这一门.

研究的目的:

重新评估MELD得分值,以实现死者供体肝移植 (DDLT) 的生存益处.
评估MELD 3.0分数与DDLT所带来的生存益处之间的关系.
为了确定当前的MELD得分值15是否需要根据MELD 3.0.0进行修订.

主要方法:

在2021年1月1日至2023年3月31日期间,在UNOS/OPTN注册表中列出的成人初级单器官肝移植 (LT) 候选人的分析.
不包括活体捐献者,LT接受者.
利用顺序分层和考克斯回归模型,在MELD 3.0分数子组中比较LT接受者和等待名单候选人的死亡率.

主要成果:

与等待名单候选人 (HR 0.05) 相比,LT接受者经过调整后的死亡风险 (95%降低) 显著降低 (HR 0.05).
在MELD 3.0分数为12及以上时,DDLT的生存益处出现.
在MELD 3.0分数为12-14时,DDLT使死亡率降低了46% (HR0.54);由于LT后死亡率更高,在MELD 3.0分数12以下没有观察到显著的益处.

结论:

MELD 3.0分数表明,DDLT从12分开始提供了生存益处,挑战了长期以来的15分门.
虽然MELD 3.0是有价值的,但它并不涵盖LT候选症的所有关键因素,例如,肝脏脑病,虚弱和生活质量.
超越MELD 3.0的全面患者评估对于最佳的LT决策至关重要.

关键词:

已故捐赠者的肝脏移植已故捐赠者的肝脏移植肝脏移植肝脏移植肝脏移植肝脏移植器官的分配器官的分配器官的分配生存效益的好处是生存的好处.

更多相关视频

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Published on: April 27, 2015

相关概念视频

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...